Early Career Presentation"The Genetics of Treatment-resistant Depression Defined Using Primary Care Records"Chiara Fabbri, PhD
King's College London
Early Career RIP
"Pharmacogenetics of NSAIDs: Using CYP2C9 Genotype to Guide Treatment"
Non-steroidal anti-inflammatory drugs (NSAIDs) are some of the most commonly used drugs worldwide, but have the potential to cause serious gastrointestinal, renal, and cardiovascular adverse events. Several drugs in this class are metabolized by CYP2C9, and polymorphisms in this enzyme that alter NSAID clearance may affect safety. This talk will summarize evidence supporting the association between CYP2C9 polymorphisms and NSAID exposure and discuss the recently published CPIC guidelines for usingCYP2C9 genotype to guide NSAID therapy.
Katherine Theken, PharmD, PhD
University of Pensylvannia
Copyright © 2020 the Pharmacogenomics Global Research Network. All Rights Reserved.
PGRN is a 501(c)3 Non-Profit Association
Follow us on